Evaluation of the army’s interim reference dose for GB

Journal of Toxicology and Environmental Health - Part A

Volumn 59, Issue 5-6, 2000, Pages 313-321

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001266894     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/713852149     Document Type: Article

References (35)

1. Bonderman, R. P., and Bonderman, D. P. 1971. Atypical and inhibited human serum pseudocholinesterase. A titrimetric method for differentiation. Arch. Environ. Health 22:578-581.
2. Bucci, T. J., and Parker, R. M. 1992. Toxicity Studies on Agents GB and GD (Phase II): 90Day Subchronic Study of GB (Sarin, Type II) in CD Rats. Final Report. FDA 224-85-0007. DTIC AD-A248618. Prepared by the Center for Toxicological Research, Jefferson, AR, for the U.S. Army Biomedical Research and Development Laboratory, Fort Detrick, Frederick, MD.
3. Bucci, T. J., Parker, R. M., and Gosnell, P. A. 1992. Toxicity Studies on Agents GB and GD (Phase II): Delayed Neuropathy Study of Sarin, Type II, in SPF White Leghorn Chickens. Technical Report. NCTR-TR-478, 479. DTIC AD-A257357. Prepared by the National Center for Toxicological Research, Jefferson, AR, for U.S. Army Biomedical Research and Development Laboratory, Fort Detrick, Frederick, MD.
4. Cohen, E. M., Christen, P. J., and Mobach, E. 1971. The inactivation of oximes of sarin and soman in plasma from various species. I. The influence of diacetylmonoxime on the hydrolysis of sarin. Proc. Koninklijke Nederlandse Akad. Van Wetenschappen, Ser. C, Biol. Med. Sci. 74:113-131. J. A. Cohen Memorial issue.
5. Davies, D. R., Holland, P., and Rumens, M. J. 1960. The relationship between the chemical structure and neurotoxicity of alkyl organophosphorus compounds. Br. J. Pharmacol. 15:271-278.
6. Davies, D. R., and Holland, P. 1972. Effect of oximes and atropine upon the development of delayed neurotoxic signs in chickens following poisoning by DFP and sarin. Biochem. Pharmacol. 21:3145-3151.
7. Denk, J. R. 1975. Effects of GB on Mammalian Germ Cells and Reproductive Parameters. EB-TR-74087. AD-A006503. Aberdeen Proving Ground, Edgewood, MD: Edgewood Arsenal.
8. Evans, F. T., G ray, P. W. S., Lehmann, H., and Silk, E. 1952. Sensitivity to succinylcholine in relation to serum chol inesterase. Lancet i:1129-1230.
9. Fonnum, F., and Sterri, S. H. 1981. Factors modifying the toxicity of organophosphorus compounds including soman and sarin. Fundam. Appl. Toxicol. 1:143-147.
10. Furlong, C. D., Li, W. F., Costa, L. G., Richter, R. J., Shih, D. M., and Lusis, A. J. 1998. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: Developing a mouse model for the human PON 1polymorphism. Neurotoxicology 19:645-650.
11. Goldman, M., Wilson, B. W., Kawakami, T. G., Rosenblatt, L. S., Culbertson, M. R., Schreider, J. P., Remsen, J. F., and Shifrine, M. 1988. Toxicity Studies on Agent VX. Final Report. DTIC AD-A201397. Prepared by the Laboratory for Energy-Related Health Research, University of California, Davis, CA, for the U.S. Army Medical Research and Development Command, Fort Detrick, Frederick, MD.
12. Gordon, J. J., Inns, R. H., Johnson, M. K., Leadbeater, L., Maidment, M. P., Upshall, D. G., Cooper, G. H., and Rickard, R. L. 1983. The delayed neuropathic effects of nerve agents and some other organophosphorus compounds. Arch. Toxicol. 52:71-82.
13. Grob, D., and Harvey, J. C. 1958. Effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphonofluoridate). J. Clin. Invest. 37:350-368.
14. Harris, H., and Whittaker, M. 1962. The serum cholinesterase variants. A study of twenty-two families selected via the "intermediate" phenotype. Ann. Hum. Genet. 26:59-72.
15. Husain, K. R., Vijayaraghavan, R., Pant, S. C., Raza, S. K., and Pandey, K. S. 1993. Delayed neurotoxic effect of sarin in mice after repeated inhalation exposure. J. Appl. Toxicol. 13:143-145.
16. La Borde, J. B., and Bates, H. K. 1986. Developmental Toxicity Study of Agent GB — DCSM Types I and II in CD Rats and NZW Rabbits. Final Report. Prepared by the National Center for Toxico-logical Research, U.S. Food and Drug Administration, Jefferson, AR, for the U.S. Army Medical Research and Development Command, Fort Detrick, MD.
17. Loewenstein-Lichtenstein, Y., Schwarz, M., Glick, D., Norgaard-Pederson, B., Zakut, H., and Soreq, H. 1995. Genetic predisposition to adverse consequences of anti-cholinesterases in "atypical" BCHE carriers. Nat. Med. 1:1082-1085.
18. Maekawa, M., Sudo, K., Dey, D. C., Ishikawa, J., Izumi, M., Kotani, K., and Kanno, T. 1997. Genetic mutations of butyrylcholine esterase identified from phenotypic abnorm alities in Japan. Clin. Chem. 43:924-929.
19. Morgan, D. P. 1989. Recognition and management of pesticide poisonings, 4th ed. EPA-540/9-88-001. Washington, DC: U.S. Environmental Protection Agency, Health Effects Division, Office of Pesticide Programs.
20. Morita, H., Yanagisawa, N., Nakajima, T., Shimizu, M., Hirabayashi, H., Okudera, H., Nohara, M., Midorikawa, Y., and Mimura, S. 1995. Sarin poisoning in Matsumoto, Japan. Lancet 346(8970): 290-293.
21. Munro, N. B., Ambrose, K. R., and Watson, A. P. 1994. Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: Implications for public protection. Environ. Health Perspect. 102: 18-38.
22. Murata, K., Araki, S., Yokoyama, K., Okumura, T., Ishimatsu, S., Takasu, N., and White, R. F. 1997. Asymptomatic sequelae to acute sarin poisoning in the central and autonomic nervous system 6months after the Tokyo subway attack. J. Neurol. 244:601-606.
23. Nakajima, T., Sato, S., Morita, H., and Yanagisawa, N. 1997. Sarin poisoning of a rescue team in the Matsumoto sarin incident in Japan. Occup. Environ. Med. 54:697-701.
24. Nakajima, T., Ohta, S., Morita, H., Midorikawa, Y., Mimura, S., and Yanagisawa, N. 1998. Epidemiological study of sarin poisoning in Matsumoto City, Japan. J. Epidemiol. 8:33-41.
25. National Research Council. 1982. Possible long-term health effects of short-term exposure to chemical agents, Vol. 1. Anticholinesterases and anticholinergics. Washington, DC: National Academy Press.
26. National Research Council. 1984. Possible long-term health effects of short-term exposure to chemical agents, Vol. 2. Cholinesterase reactivators, psychochemicals, and irritants and vesicants. Washington, DC: N ati onal Academy Press.
27. National Research Council. 1985. Possible long-term health effects of short-term exposure to chemical agents, Vol. 3. Final report. Current health status of test subjects. Washington, DC: National Academy Press.
28. Oak Ridge National Laboratory. 1996. Health Risk Assessment for the Nerve Agent GB. Draft Report. Interagency Agreement No. 1769-1769-A1. Prepared by Oak Ridge National Laboratory, Life Sciences Division, Oak Ridge, TN, for the U.S. Department of the Army, Army Environmental Center, Aberdeen Proving Ground, Edgewood, MD.
29. Registry of Toxic Effects of Chemical Substances. 1995. MEDLARS Online Information Retrieval System, National Library of Medicine, Bethesda, MD.
30. Somani, S. M., ed. 1992. Chemical warfare agents. San Diego, CA: Academic.
31. Traina, M. E., and Serpietri, L. A. 1984. Changes in the levels and forms of rat plasma cholinesterases during chronic diisopropylphosphorofluoridate intoxication. Biochem. Pharmacol. 33:645-653.
32. U.S. Environmental Protection Agency. 1989. Ethion Reference Dose for Chronic Oral Exposure. Integrated Risk Information System (IRIS). Online file, accessed 22July 1998. http://www.epa.gov /iris
33. U.S. Environmental Protection Agency. 1992. Malathion Reference Dose for Chronic Oral Exposure. Integrated Risk Information System (IRIS). Online file, accessed 22July 1998. http://www.epa. gov/iris
34. Yokoyama, K., Araki, S., Murata, K., Nishikitani, M., Okumura, T., Ishimatsu, S., Takasu, N., and White, R. F. 1998a. Chronic neurobehavioral effects of Tokyo subway sarin poisoning in relation to posttraumatic stress disorder. Arch. Environ. Health 53:249-256.
35. Yokoyama, K., Araki, S., Murata, K., Nishikitani, M., Okumura, T., Ishimatsu, S., and Takasu, N. 1998b. Chronic neurobehavioral and central and autonomic nervous system effects of Tokyo subway sarin poisoning. J. Physiol. (Paris) 92:317-323.